The export of composite diagnostic or laboratory reagents from the Netherlands has experienced an upward trajectory from 2013 to 2023. In 2023, the value of exports stood at 2.7466 billion US Dollars. This growth shows resilience with noticeable year-on-year variations, particularly in 2013 (34.56%) and 2014 (23.76%). Over the last two years, the growth has been stable albeit modest with year-on-year increases of 4.07% in 2022 and 3.84% in 2023. The compound annual growth rate (CAGR) over the past five years has averaged 3.7%, reflecting steady expansion in the sector.
Moving forward, projected data from 2024 to 2028 suggests continued growth at a moderate pace, with the forecasted 5-year CAGR estimated at 2.53%, translating to a total growth rate of 13.29%. This indicates sustained industry expansion albeit at a decelerating rate.
Key trends to watch for in the future include potential technological advancements in diagnostic and laboratory reagents that may drive higher export values. Additionally, changes in global health policies and economic conditions could impact the trade dynamics significantly.
